These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 2880291)

  • 1. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
    Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
    N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
    Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
    Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
    Choy FY; Wei C; Applegarth DA; McGillivray BC
    Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity.
    Choy FY; Woo M; Der Kaloustian VM
    Am J Med Genet; 1991 Jun; 39(4):466-71. PubMed ID: 1877626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.
    Church HJ; Cooper A; Stewart F; Thornton CM; Wraith JE
    Eur J Hum Genet; 2004 Nov; 12(11):975-8. PubMed ID: 15292921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight linkage between type III Gaucher's disease (Norrbottnian type) and a MspI polymorphism within the gene for human glucocerebrosidase.
    Dahl N; Erikson A; Hammarström-Heeroma K; Pettersson U
    Genomics; 1988 Nov; 3(4):296-8. PubMed ID: 2468600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain.
    Pérez-Calvo J; Bernal M; Giraldo P; Torralba MA; Civeira F; Giralt M; Pocovi M
    Eur J Med Res; 2000 Jun; 5(6):231-5. PubMed ID: 10882637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel frameshift mutation (Pro171fsX21) in neonatal type 2 Gaucher's disease.
    Park HW; Lee Y; Kim GH; Lee BS; Kim KS; Yoo HW; Kim EA
    Gene; 2012 Oct; 507(2):170-3. PubMed ID: 22772462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    Lancet; 1989 Aug; 2(8659):349-52. PubMed ID: 2569551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.
    Sinclair G; Choy FY; Humphries L
    Blood Cells Mol Dis; 1998 Dec; 24(4):420-7. PubMed ID: 9851895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetic approaches to neurologic diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1550-3. PubMed ID: 2698300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuronopathic form.
    Masuno M; Tomatsu S; Sukegawa K; Orii T
    Hum Genet; 1990 Jan; 84(2):203-6. PubMed ID: 1967589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.